The painless form of acute myocardial infarction

Česká verzia

Authors: S. Janoušek
Authors place of work: Interní kardiologická klinika LF MU a FN Brno pracoviště Bohunice
Published in the journal: Kardiol Rev Int Med 2007, 9(4): 222-228
Category: Editorial

Summary

The results of studies and data from registries show that prevalence of acute myocardial infarction (AMI) without chest pain is relatively high. The main important subgroups with high rate of painless AMI groups are older patients, women, diabetics and hypertonics. The main presenting symptoms included dyspnoea (or heart failure), nausea and vomitus (or other gastrointestinal complaints), diaphoresis, palpitation, syncopes, arrhythmias up to cardiac arrest, sudden malaise or weakness, strokes, and in the elderly also confusion or sudden worsening of cognitive functions. The observation show that is very threatened group of patients what is consequence of many adverse factors. Their arrival in hospital in mean is delayed with comparison of patients with typical symptoms and in addition more than 20% was not admitted under diagnosis of AMI. That is in connection with fact, that ECG pattern of ST elevation (STEMI) is there less frequent. the establishing of diagnosis is delayed. Moreover in patients with correct diagnosis of AMI the establishing of diagnosis is delayed. That all is reason for less frequent acute reperfusion therapy that is often also significantly delayed. Also their entry, consecutive and discharge pharmacotherapy is suboptimal in comparison with actual guidelines of AMI treatment. They also less frequent undergo coronarography, less commonly included into cardiac rehabilitation program or followed by cardiologists. The result of that all is unfavorable hospitalization prognosis with high rate of heavy complications and significantly higher short- and long-time mortality. It is difficult to find the way to improve prognosis of that group. Besides educational program about alternative of atypical AMI presentation not only for patients but mostly for medical staff the possibility of early ECG record and troponin analysis also in cases without chest pain is suggesting. Definitely the emphasis on invasive diagnostics and aggressive pharmacotherapy is necessary in these patients.

Key words:
acute myocardial infarction, painless form, atypical symptoms, prevalence, risk groups, treatment, complications, prognosis

Zdroje

1. Swap CJ, Nagurney JT. Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes. JAMA 2005; 294: 2623-2629.

2. Sejil S. Janand-Delenne B. Avierinos JF et al. Six-year follow-up a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia. Diabet Med 2006; 23: 1186-1191.

3. Valensi P, Paries J, Brulport-Cerisier V et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care 2005; 28: 2722-2727.

4. Sajadieh A, Nielsen OW, Rasmussen V et al. Prevalence and prognostic significance of daily-life silent myocardial ischaemia in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2005; 26: 1402-1409.

5. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912; 59: 2015-2020.

6. Pasceri V, Cianflone D, Finocchiaro ML et al. Relation between myocardial infarction siteand pain location in Q-wave. myocardial infarction. Am J Cardiol 1995; 75: 224-227.

7. Culi V, Miri D, Eterovi D. Correlation between symptomatology and site of acute myocardial infarction. Int J Cardiol 2001; 77: 163-168.

8. Bean WB. Masquerades of myocardial infarction. Lancet 1977; 1: 1044-1046.

9. Joly L, Benetos A. Clinical specificities of coronary artery disease in the elderly. Arch Mal Coeur Vaiss 2006; 4: 29-33.

10. Brieger D, Eagle KA, Goodman SG et al. Acute coronary syndromes without chest pain, An underdiagnosed and undertreated high-risk group: Insights from the global registry of acute coronary events. Chest 2004; 126: 461-469.

11. Rich MW. Epidemiology, clinical features, and prognosis of acute myocardial infarction in the elderly. Am J Geriatr Cardiol 2006; 15: 7-11.

12. Aronow WS. Silent MI. Prevalence and prognosis in older patients diagnosed by routine electrocardiograms. Geriatrics 2003; 58: 24-26.

13. Dorsch MF, Lawrance RA, Sapsford RJ et al. Poor prognosis of patients presenting with symptomatic myocardial infarction but without chest pain. Heart 2001; 86: 494-498.

14. Patel H, Rosengren A, Ekman I. Symptoms in acute coronary syndromes: does sex make a difference? Am Heart J 2004; 148: 27-33.

15. Lovlien M, Schei B, Hole T. Women with myocardial infarction are less likely than men to experience chest symptoms. Scand Cardiovasc J 2006; 40: 342-347.

16. Bayer AJ, Chada JS, Farag RR et al. Changing presentation of myocardial infarction with increasing old age. J Am Geriatr Soc 986; 34: 263-266.

17. Canto JG, Shlipak MG, Rogers WJ et al. Prevalence, Clinical Characteristics, and Mortality Among Patients With Myocardial Infarction Presenting Without Chest Pain. JAMA 2000; 283: 3223-3229.

18. Teoh M, Lalondrelle S, Roughton M et al. Acute coronary syndromes and their presentation in Asian and Caucasian patients in Britain. Heart 2007; 93: 183-188.

19. Herlitz J, Karlson BW, Richter A et al. Prognosis for patients with initially suspected acute myocardial infarction in relation to presence of chest pain. Clin Cardiol 1992; 15: 570-576.

20. Goldstein RE, Boccuzzi SJ, Cruess D. Prognosis after hospitalization for acute myocardial infarction not accompanied by typical ischemic chest pain. The multicenter diltiazem postinfarction trial research group. Am J Med 1995; 99: 123-131.

21. Macfarlane PW, Norrie J, WOSCOPS Executive Committee. The value of the electrocardiogram in risk assessment in primary prevention: experience from the West of Scotland Coronary Prevention Study. J Electrocardiol 2007; 40: 101-109.

22. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med 1984; 311: 1144-1147.

23. DeLuca AJ, Kaplan S, Aronow WS et al. Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi strčess test in aptients with versus without diabetes mellitus. Am J Cardiol 2006; 98: 1045-1046.

24. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000; 21: 1502-1513.

25. Uretsky BF, Farquhar DS, Berezin AK et al. Symptomatic myocardial infarction without chest pain: prevalence and clinical course. Am J Cardiol 1977; 40: 498-503.

26. Milner KA, Funk M, Arnold A et al. Typical symptoms are predictive of acute coronary syndromes in women. Am Heart J 2002; 143: 283-288.

27. Then KL, Rankin JA, Fofonoff DA. Atypical presentation of acute myocardial infarction in 3 age groups. Heart Lung 2001; 30: 285-293.

28. Devon HA, Zerwic JJ. Symptoms of acute coronary syndromes: are there gender differences? A review of the literature. Heart Lung 2002; 31: 235-245.

29. Madias JE, Chintalapaly G, Choudry M et al. Correlates and in-hospital outcome of painless presentation of acute myocardial infarction: a prospective study of a consecutive series of patients admitted to the coronary care unit. J Investig Med 1995; 43: 567-574.

30. Aronow WS. Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patients. Am J Cardiol 1987; 60: 1182.

31. Weaver WD, Litwin PE, Martin JS et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction: The MITI Project Group. J Am Coll Cardiol 1991; 18: 657-662.

32. Lerner DJ, Kannel VVB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383-390.

33. Goldberg R, Goff D, Cooper L et al. Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial; Rapid Early Action for Coronary Treatment. Coron Artery Dis 2000; 11: 399-407.

34. Aronow WS, Ahn C, Mercando AD, Epstein S. Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary artery events in older persons with chronic renal insufficiency and with normal renal function. Am J Cardiol 2000; 86: 1142-1143.

35. Nakamura S, Uzu T, Inenaga T, Kimura G. Prediction of coronary artery disease and cardiac events using electrocardiographic changes during hemodialysis. Am J Kid Dis 2000; 36: 592-599.

36. Zawada ET, Stinson JB, Done G. New perspectives on coronary artery disease in hemodialysis patients. South Med J 1982; 75: 694-696.

37. Muller RT, Gould LA, Betzu R et al. Painless myocardial infarction in the elderly. Am Heart J 1990; 119: 202-204.

38. Acharya DU, Shekhar YC, Aggarwal A, Anand IS. Lack of pain during myocardial infarction in diabetics: is autonomic dysfunction responsible? Am J Cardiol 1991; 68: 793-796.

39. Ambepityia G, Kopelman PG, Ingram D et al. Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol 1990; 15: 72-77.

40. Bradley RF, Schonfeld A. Diminished pain in diabetic patients with acute myocardial infarction. Geriatrics 1962; 17: 322-326.

41. Meischke H, Larson MP, Eisenberg MS. Gender differences in reported symptoms for acute myocardial infarction: Impact of pre-hospital delay time interval. Am J Emerg Med 1998; 16: 363-366.

42. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-322.

43. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction. Every minute of delay counts. Circulation. 2004; 109: 1223-1225.

44. Miyamoto S, Goto Y, Sumida H, Yasuda et al. Risk factors and physicial aktivity levels at the onset of acute myocardial infarction in young men. J Cardiol 2000; 36: 75-83.

45. Granger CB, Califf RM, Young S et al. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The thrombolysis and angioplasty in myocardial infarction (TAMI) study group. J Am Coll Cardiol 1993; 21: 920-925.

46. Mak KH, Faxon DP. Clinical studies on coronary revascularization in patients with type 2 diabetes. Eur Heart J 2003; 24: 1087-1103.

47. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152.

48. Nighoghossian N, Cakmak S, Derex L et al. Silent coronaropathy: usefulness of dobutamine stress echocardiography in ischemic stroke. Eur Neurol 2006; 56: 211-216.

49. Puente A, Roffe F, Chimal JL, Gomez E et al. Non-invasive evaluation of coronary atherosclerotic disease in patients with silent ischemia: usefulness of myocardial perfusion spect, electrical, angiographic, and imaging correlation. Arch Cardiol Mex 2005; 75: 29-34.

50. Biagini E, Schinkel AF, Bax JJ et al. Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart 2005; 91: 737-742.

51. Nowak KA. Atypical chest pain in the elderly. Nurse Pract 1997; 22: 11-14.

52. Rouan GW, Hedges JR, Toltzis R et al. A chest pain clinic to improve the follow-up of patients released from an urban university teaching hospital emergency department. Ann Emerg Med 1987; 16: 1145-1150.

53. Lee TH, Rouan GW, Weisberg MC et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987; 60: 219-224.

54. McCarthy BD, Beshansky JR, D'Agostino RB, Selker HP. Missed diagnosis of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med 1993; 22: 579-582.

55. Khan IA, Wattanasuwan N. Role of biochemical markers in diagnosis of myocardial infarction. Int J Cardiol 2005; 104: 238-240.

56. Bonnefoy E, Godon P, Kirkorian G et al. Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta. Acta Cardiol 2005; 60: 165-170.

57. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005; 142: 786-791.

58. Van Lente F, McErlean ES, DeLuca SA et al. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol 1999; 33: 471-478.

59. Norris JW, Hachinski VC, Myers MG et al. Serum cardiac enzymes in stroke. Stroke 1979; 10: 548-553.

60. Giannitsis E, Muller-Bardorff M, Kurowski V et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211-217.

61. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96: 2953-2958.

62. Wong CK, White HD. Recognising painless heart attacks. Heart 2002; 87: 3-5.